Meet BOC Sciences at AAPS PharmSci 360 2026 — Booth #811
Oct. 25–28, 2026, New Orleans, LA
Register
Website Search
Google Search
Shopping Cart
0
Tel:
Email:
Toggle navigation
0
Home
Products
BY PRODUCT TYPE
Drug Discovery
Inhibitor
PROTAC
Vaccine Adjuvants
Impurities
Metabolites
ADCs
Pharmaceutical Excipients
APIs
GMP
Intermediates
Chemistry
Amino Acids
Chiral Compounds
Flavor & Fragrance
Natural Compounds
Stable Isotope Labelled Compounds
Superparamagnetic Iron Oxide Nano/Micro Particles Preparation
Main Product
Life Science
Nanoemulsions
Oligonucleotides
Enzymes
Stem Cell Molecule
Fluorescent Probes
Chemiluminescent Substrates
Carbohydrates, Nucleosides & Nucleotides
Lipid
Research Area
BY SIGNALING PATHWAYS
Signaling Pathway
Angiogenesis
Anti-infection
Apoptosis
Autophagy
Cell Cycle
Cytoskeletal Signaling
DNA Damage
Epigenetics
GPCR & G Protein
Immunology & Inflammation
JAK/STAT
MAPK
Membrane Transporter/Ion Channel
Metabolism
Neuronal Signaling
NF-κB
PI3K/Akt/mTOR
Proteases
Protein Tyrosine Kinase
Stem Cells & Wnt
TGF-beta/Smad
Ubiquitin
Vitamin D Related
Services
Nanoemulsions Technology
Nanoemulsions cGMP Manufacturing
Nanoemulsions Characterization
Process Development & Stabilization Strategies
Analytical Services
XDC Analysis Services
Crystallization Services
Lab Testing Services
Animal Testing for Inhibitors
Contract Purification
Impurity Identification & Analysis Services
Custom Synthesis
Glycogen Synthesis
Glycans Synthesis
Chiral Synthesis and Resolution
Nucleoside Synthesis Services
Nucleotide Synthesis Services
Carbohydrate Services
AI Drug Discovery
Conjugated Drug Development
RNA Therapeutics Development
ADMET & Developability
Drug Discovery
Microbial Fermentation Services
Targeted Protein Degradation Platform (PROTACs)
Drug design services
Integrated Services on Drug Discovery
Aesthetic Medicine Ingredients Services
RNA Technology
BOC Nano
TM
Platform
Bioconjugation
Isotope Labeling Services
Fluorescent Labeling Service
Drug Delivery
Cell Based Drug Delivery
Hydrogel Drug Delivery
Liposome Drug Delivery
Microspheres Drug Delivery
Nanoparticle Drug Delivery
Nanotechnology in Drug Delivery
Peptide-Based Drug Delivery
Polymer-Based Drug Delivery
Exosome-Based Drug Delivery
Carbohydrate-Based Drug Delivery
mRNA Drug Delivery
RNA Drug Delivery
siRNA Drug Delivery
XDC Bioconjugation
Conjugation Methods
Lys Conjugation
Cys Conjugation
Site-Specific Conjugation
Disulfide Conjugation
Enzymatic Conjugation
Mod-ADClink
TM
ADC Linker Design
Antibody Modification and Conjugation
Targeting Drug Delivery
Antibody-Drug Conjugates
Antibody-Oligonucleotide Conjugates
Peptide-Drug Conjugates
Small Molecule-Drug Conjugates
Peptide-Oligonucleotide Conjugates
Natural Products-Active Molecules Conjugates
RNAi Delivery
GalNAc-siRNA Conjugates
Antibody-siRNA Conjugates
Peptide-siRNA Conjugates
Aptamer-Drug Conjugates
Antibody-PNA Conjugates
CDMO
cGMP Capacity
Ingredient Combination
CMC
Formulation Services
Process Development
Quality Control
License out
Antibody Peptide Oligonucleotide Conjugation (APOC™)
Glycosylated Antibody-Oligonucleotide Conjugates Technology (GlycoAOCT™)
Lipid-based Chem Enhanced Delivery System (LipCeDS™)
About Us
Webinar
Events
Privacy and how to get started
Contact Us
Support
Careers
Our Distributor
Chemistry Scholarship Program
Publications
Home
Publications
Publications
The multi-kinase inhibitor pazopanib targets hepatic stellate cell activation and apoptosis alleviating progression of liver fibrosis Elshal, M., Abu-Elsaad, N., El-Karef, A., & Ibrahim, T. M.
Naunyn-Schmiedeberg's archives of pharmacology 388.12 (2015): 1293-1304.
First
«
23
24
25
26
27
28
29
30
31
32
»
Last
